A RANDOMIZED CONTROL STUDY TO EVALUATE THE EFFECTIVENESS OF LETERMOVIR PROPHYLAXIS VERSUS CONVENTIONAL THERAPY IN LIVER TRANSPLANT RECIPIENTS.
About
Brief Summary
This study has not yet been registered on ClinicalTrials.gov, which is currently a pre-requisite for display of detailed eligibility criteria.
- If you need assistance with ClinicalTrials.gov registration for an oncology study, please contact the Jonsson Comprehensive Cancer Center's Office of Regulatory Compliance.
- If you need assistance with ClinicalTrials.gov registration for a non-oncology study, please contact the Office of Regulatory Affairs.
Eligibility
Minimum Age
Maximum Age
Join this Trial
Contact our clinical trial navigators for opportunities that may be suitable for you
Study Stats
Protocol No.
25-1135
Principal Investigator
Contact